Teligent, Inc. (NASDAQ:TLGT) hit a new 52-week low during trading on Tuesday . The stock traded as low as $5.61 and last traded at $5.61, with a volume of 122,397 shares traded. The stock had previously closed at $5.81.
A number of equities research analysts have recently issued reports on the company. Roth Capital set a $9.00 target price on Teligent and gave the company a “buy” rating in a research note on Wednesday, August 9th. BidaskClub downgraded Teligent from a “hold” rating to a “sell” rating in a report on Monday, July 24th. Canaccord Genuity reissued a “buy” rating and issued a $11.00 price target on shares of Teligent in a report on Tuesday, August 8th. Deutsche Bank AG reduced their price target on Teligent from $9.00 to $8.00 and set a “hold” rating for the company in a report on Monday, August 14th. Finally, ValuEngine downgraded Teligent from a “hold” rating to a “sell” rating in a report on Tuesday, July 25th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company. Teligent presently has an average rating of “Hold” and a consensus target price of $9.33.
The company has a 50-day moving average price of $6.71 and a 200-day moving average price of $6.71. The stock’s market cap is $304.33 million.
Teligent (NASDAQ:TLGT) last released its earnings results on Tuesday, August 8th. The company reported ($0.02) earnings per share for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.04). Teligent had a positive return on equity of 1.49% and a negative net margin of 11.36%. The firm had revenue of $18.40 million for the quarter, compared to analyst estimates of $20.11 million. During the same period last year, the business earned $0.02 earnings per share. The firm’s quarterly revenue was up 7.4% compared to the same quarter last year. On average, analysts expect that Teligent, Inc. will post $0.07 earnings per share for the current year.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Parkwood LLC acquired a new stake in Teligent during the second quarter valued at approximately $112,000. UBS Asset Management Americas Inc. acquired a new stake in Teligent during the first quarter valued at approximately $170,000. Renaissance Technologies LLC acquired a new stake in Teligent during the first quarter valued at approximately $198,000. American International Group Inc. boosted its holdings in Teligent by 7.1% during the first quarter. American International Group Inc. now owns 25,488 shares of the company’s stock valued at $199,000 after purchasing an additional 1,680 shares in the last quarter. Finally, Voya Investment Management LLC boosted its holdings in Teligent by 16.1% during the second quarter. Voya Investment Management LLC now owns 23,342 shares of the company’s stock valued at $214,000 after purchasing an additional 3,234 shares in the last quarter. 66.56% of the stock is currently owned by institutional investors.
COPYRIGHT VIOLATION NOTICE: This piece of content was published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece of content on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright laws. The original version of this piece of content can be accessed at https://www.com-unik.info/2017/10/31/teligent-inc-tlgt-reaches-new-52-week-low-at-5-61.html.
Teligent Company Profile
Teligent, Inc is a specialty generic pharmaceutical company. Under the Company’s own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 16 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2016.
What are top analysts saying about Teligent Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Teligent Inc. and related companies.